CHM Insider Trading (Chimeric Therapeutics)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$2,940.00
Insider Selling (Last 12 Months): A$0.00
Chimeric Therapeutics Share Price & Price History
Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 03/11/2021 11:04 AM ET
The Safest Option in Trades!
From Tradewins | Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.
And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
Chimeric Therapeutics Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 6/29/2022 | Leslie (Mi Ok) Chong | Insider | Buy | 30,000 | A$0.10 | A$2,940.00 | | |
| 3/25/2022 | Leslie (Mi Ok) Chong | Insider | Issued | 3,905 | A$0.15 | A$585.75 | | |
| 8/4/2021 | George Matcham | Insider | Buy | 500,000 | A$0.33 | A$166,000.00 | | |
| 3/8/2021 | Cynthia Elkins | Insider | Buy | 24,800 | A$0.32 | A$7,886.40 | | |
A One Stop Shop for Everything Futures Trading
From RJO Futures | Ad
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.
SEC Filings (Institutional Ownership Changes) for Chimeric Therapeutics (ASX:CHM)
Chimeric Therapeutics Limited researches, develops, and commercializes cell therapies for cancer in Australia. The company develops CLTX CAR T cell therapy that is in Phase I clinical study for Glioblastoma; and CDH17 CAR T, which is in preclinical study for neuroendocrine tumours, as well as colorectal, pancreatic, and gastric cancer. It has a strategic partnership with OncoBay Clinical for the development program of CLTX CAR T. The company was incorporated in 2020 and is based in Carlton, Australia.
Read More on Chimeric Therapeutics
Today's Range
Now: N/A
50 Day Range
MA: N/A
52 Week Range
Now: N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Chimeric Therapeutics?
